Last checked at 13 Oct 2010 16:00
Directors' Shareholdings/Issue of equity
13 October 2010 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has today issued a total of 255,660 new ordinary shares of 1p each in the Company ("New Ordinary Shares") at a price of 17.00 pence per share.
The four non-executive directors named below have elected to take New Ordinary Shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 July 2010 to 30 September 2010.
Paul Mitchell has elected to take New Ordinary Shares in lieu of £2,704 of salary in respect of the period 1 July 2010 to 30 September 2010.
The Company has issued 112,736 New Ordinary Shares to a former director of the Company as a final discharge of contractual commitments.
Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 19 October 2010. Following the issue of these new shares the Company has a total of 130,528,663 ordinary shares of 1p each in issue.
Following this issue, the directors' beneficial interests are as follows:
| Name of Director | Number of New Ordinary Shares issued in lieu of fees/salary
| Holding of shares following issue of New Ordinary Shares
| % of enlarged issued share capital |
| Nigel Keen | 49,019 | 5,591,069 | 4.29 |
| Dr Edwin Snape (1) | 35,294 | 4,361,955 | 3.34 |
| Sir Duncan Nichol | 21,176 | 583,645 | 0.45 |
| Julian Cazalet | 28,051 | 3,430,933 | 2.63 |
| Paul Mitchell | 9,384 | 204,501 | 0.16 |
(1) Includes shares held as a principal of Nexus Medical Partners II, L.P.
For further information, please contact:-
Deltex Medical Group plc 01243 774 837Nigel Keen, Chairman Ewan Phillips, Chief Executive Paul Mitchell, Finance Director
Nominated Adviser and Broker 0207 614 5917
Arden Partners plc
Christopher Hardie
Matthew Armitt